NLRP3 and rheumatoid arthritis: Compared to our findings concerning the anti-arthritic effect of ticagrelor through modulating ferroptosis and NLRP3 expression, other approved protective agents against RA have been demonstrated to target ferroptosis-associated oxidative damage and NLRP3 activation.